■ Books
|
■ Published papers
|
1.
|
Original article
|
Lung Tumor Cell Recruitment Assay. 2019/02
|
|
2.
|
Original article
|
Paradoxical counteraction by imatinib against cell death in myeloid progenitor 32D cells expressing p210BCR-ABL. 2018/08/03
|
|
3.
|
Original article
|
C1D is not directly involved in the repair of UV-damaged DNA but protects cells from oxidative stress by regulating gene expressions in human cell lines. 2018/08
|
|
4.
|
Original article
|
Direct Melanoma Cell Contact Induces Stromal Cell Autocrine Prostaglandin E2-EP4 Receptor Signaling That Drives Tumor Growth, Angiogenesis, and Metastasis. 2015/10
|
|
5.
|
Original article
|
Drug Targeting Based on a New Concept-Targeting Against TLR4 as an Example. 2015
|
|
6.
|
Original article
|
Nobiletin, a polymethoxy flavonoid, suppresses bone resorption by inhibiting NFκB-dependent prostaglandin E synthesis in osteoblasts and prevents bone loss due to estrogen deficiency. 2011/01
|
|
7.
|
Original article
|
Naringin suppresses, osteoclast formation and enhances bone mass in mice. 2009/06
|
|
8.
|
Original article
|
Hyaluronan inhibits bone resorption by suppressing prostaglandin E synthesis in osteoblasts treated with interleukin-1. 2009/01
|
|
9.
|
Original article
|
A novel carborane analog, BE360, with a carbon-containing polyhedral boron-cluster is a new selective estrogen receptor modulator for bone. 2009/01
|
|
10.
|
Original article
|
1α,25(OH)2 D3-26,23-lactam, a novel vitamin D3 analog, acts as a vitamin D3 antagonist in human prostate cancer cells. 2008/08
|
|
11.
|
Original article
|
Novel vitamin D3 analogs, 1α,25(OH)2D3-26,23-lactam (DLAMs), antagonize bone resorption via suppressing RANKL expression in osteoblasts. 2008/05
|
|
12.
|
Original article
|
Prostaglandin E receptor EP4 antagonist suppresses lipopolysaccharide-induced osteoclast formation and inflammatory bone loss. 2007/04
|
|
13.
|
Original article
|
Capsaicin, a ligand for vanilloid receptor-1, transduces suppressive signal for osteoclast differentiation in bone. 2007/04
|
|
14.
|
Original article
|
Prostaglandin E receptor EP4 antagonist suppresses osteolysis due to bone metastasis of mouse malignant melanoma cells. 2007/01
|
|
Display 5 items
|
|
Display all(14)
|
|
■ Academic conference presentation
|
■ Research grants & projects
| 1. |
2012/04～2015/03
|
Role of C1D in metastasis of cancer and drug discovery research (Key Word : protein degradation, C1D, nucleosome, IL-8 transcription, metastasis)
|
|
■ Research areas
|
Tumor biology, Tumor diagnostics and therapeutics, Cell biology (Key Word：cancer metastasis, pre-metastatic niche, tumor microenvironment)
|
|
■ Education
| 1. |
2004/04～2007/03
|
〔Doctoral course〕 Department of Life Science and Biotechnology, Tokyo University of Agriculture and Technology, Completed,
|
| 2. |
1999/04～2001/03
|
〔Master degree program〕, Tokyo University of Pharmacy and Life Science, Completed,
|
|
